ESHRE. Value of mid-luteal oestradiol level: prognostic implications for IVF

By  

Human Reproduction, Vol. 16, Iss. 11, 2001-11 ,pp. : 2476-2476

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles

By Albano C.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1426-1430

Oxford University Press

Access to resources Recommend Favorite

Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.

By Valbuena D   Pellicer A   Guanes P P   Remohí J   Simón C  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2118-2122

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A rapid decline in serum oestradiol concentrations around the mid-luteal phase had no adverse effect on outcome in 763 assisted reproduction cycles

By Hung Yu Ng Ernest   Shu Biu Yeung William   Yee Lan Lau Estella   Wai Ki So William  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1903-1908

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

By Ludwig M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2437-2441

Oxford University Press

Access to resources Recommend Favorite